Clinical Trials Logo

Filter by:
NCT ID: NCT06424288 Recruiting - Heart Failure Clinical Trials

A Study to Test Whether BI 690517 in Combination With Empagliflozin Helps People With Heart Failure

Start date: June 4, 2024
Phase: Phase 3
Study type: Interventional

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether BI 690517 in combination with empagliflozin helps people with heart failure. Participants are put into 2 groups by chance. Every participant has an equal chance of being in each group. The groups are: - BI 690517 and empagliflozin group: participants take BI 690517 and empagliflozin as tablets once a day. - Placebo and empagliflozin group: participants take placebo and empagliflozin as tablets once a day. Participants can stay in the study as long as they benefit from treatment and can tolerate it. During this time, they visit their doctors regularly. The doctors regularly check participants' health and take note of any unwanted effects. The study staff may also contact the participants by phone. Participants also regularly answer questions about their well-being. The study does not have a fixed duration. It continues until we have enough data to see if the treatment is working.

NCT ID: NCT06424158 Recruiting - Clinical trials for Scoliosis; Adolescence

Massage Therapy After Thoracic or Lumbar Surgery

Start date: February 17, 2021
Phase: N/A
Study type: Interventional

The purpose of this research is to look at the effect of massage therapy on the pain, anxiety, and quality of life that pediatric patients have after undergoing spinal fusion surgery. This is a single-site, prospective, randomized, interventional study design that will involve post-thoracic and post-lumbar spinal fusion surgeries of pediatric patients from 7 to 19 years of age that present to Cook Children's Medical Center in Fort Worth, Texas. These patients will be identified prior to their scheduled spinal fusion surgery and recruited to enroll in the study. The planned spinal fusion surgeries are not considered part of this research project, but rather considered standard of care and would occur whether the patient is enrolled in this project or not. Enrolled participants will be followed during their inpatient stay and through their subsequent follow-up visits at weeks 2, 6, and 12. Participants will be randomly assigned to either a massage therapy group or a group that receives the standard (normal) care for recovery after surgery. The final study involvement will occur at week 16 (post-hospital discharge) where a study team member will administer a quality of life (PedsQL) questionnaire via phone or mail with the subject. Data will be collected after study related procedures are completed.

NCT ID: NCT06424119 Recruiting - Clinical trials for Cardiovascular Diseases

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

CREDIBLE
Start date: April 26, 2024
Phase: N/A
Study type: Interventional

The goal of this prospective study is to evaluate whether the Intensive Cardiac Rehabilitation (ICR) program provides incremental benefits over the Traditional Cardiac Rehabilitation (TCR) program, defined by readmission costs. The study aims to confirm: - That ICR is associated with better outcomes than TCR, defined as lower readmission costs, lower incidence of major adverse cardiovascular events (MACE), and improvement in biomarkers, epigenetic markers, and inflammatory markers. - The addition of food to the ICR program will further improve these outcomes. ICR-eligible participants - Will be randomized into one of three groups: (1) ICR 72 session program with home-delivered C2life® supplied food, (2) ICR 72 session without C2life® supplied food, or (3) TCR 36 session program without C2life supplied food - Biometric measurements and laboratory measurements will be performed at entry into the rehab intervention, discharge from rehab intervention, and at 6 months after discharge. - Epigenetic measurements will be performed at admission and discharge from the rehab intervention

NCT ID: NCT06423963 Recruiting - Pancreatic Cancer Clinical Trials

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

Start date: February 8, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).

NCT ID: NCT06423950 Recruiting - Pediatric Cancer Clinical Trials

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Start date: April 30, 2024
Phase:
Study type: Observational

To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.

NCT ID: NCT06423638 Recruiting - Stress Clinical Trials

Feasibility of Virtual Tai Chi Easy for Registered Nurses

TCERN
Start date: December 22, 2023
Phase: N/A
Study type: Interventional

This study will examine the feasibility of virtual Tai Chi Easy training for registered nurses and see if participation results in changes in symptoms of transition shock, healthcare-related psychological traumatic stress, burnout, somatic symptoms, and intention to quit. Participants will do virtual Tai Chi Easy for 2 hours per week and practice on their own for 40 minutes per week. The study will last six weeks. Surveys will be completed in REDCap before, during, and after the intervention.

NCT ID: NCT06422689 Recruiting - Asthma Clinical Trials

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

ANCHOR
Start date: May 10, 2024
Phase: Phase 4
Study type: Interventional

ANCHOR is a prospective, multi-center, phase IV, interventional, single-arm, open-label study of 2,000 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare the asthma exacerbation rates before and after switching from albuterol or levalbuterol to albuterol plus budesonide inhalation aerosol as rescue therapy.

NCT ID: NCT06422442 Recruiting - Stuttering, Adult Clinical Trials

Information Processing Biases in Adults Who Stutter

Start date: September 11, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to examine whether stuttering is associated with a tendency to attend more quickly or for longer durations to threat-related information in the environment (threat-related attention bias). The main questions it aims to answer are: Do adults who stutter, relative to adults who do not stutter, attend to threat-related stimuli more than neutral information? Are attentional biases observed across different types of threat or are they specific to threats related to stuttering experiences? Do measures of attention bias explain individual differences in psychological reactions among adults who stutter?

NCT ID: NCT06422364 Recruiting - Sleep Clinical Trials

Assessment of the Safety and Efficacy of Weighted Wearable Blankets in Healthy Infants During Sleep

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess the risk of an infant overheating and/or experiencing lowered respiration via measurement of vital signs in a controlled clinical environment while wearing a weighted wearable blanket in male/female infant healthy volunteers, 0-12 months of age. The main questions it aims to answer are: Primary Objective: To pilot an investigation on the impact of weighted wearable blankets on vital signs and infant movement in healthy infants during nap polysomnogram. Secondar Objective: To investigate the efficacy of weighted wearable blankets on sleep patterns in healthy infants during overnight sleep.

NCT ID: NCT06421766 Recruiting - Hearing Loss Clinical Trials

Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures

Start date: March 8, 2024
Phase:
Study type: Observational

This retrospective study is conducted to gain more knowledge on use and complications of 3mm long implants used in percutaneous (through the skin) bone-anchored hearing system (BAHS) surgeries in adults. Patients included have already been treated and recieved an implant with the wide diameter (Ø: 4.5 mm) design, either of 3- or 4mm length. The main purpose of the study is to investigate implant survival three months after implantation.